more
The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy

This article reviews the evolution of AAV-mediated gene therapy for DMD, focusing on dystrophin structure, μDys engineering, systemic delivery strategies, clinical trial outcomes, and emerging solutions such as myotropic AAVs and gene editing platforms designed to overcome current limitations and enhance therapeutic efficacy.